Works matching IS 21989788 AND DT 2023 AND VI 10 AND IP 4
Results: 16
Author Correction: Signal Detection and Assessment of Herb–Drug Interactions: Saudi Food and Drug Authority Experience.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Acknowledgement to Referees.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 499, doi. 10.1007/s40801-023-00404-z
- Publication type:
- Article
Clinical Characteristics and Treatment of Irritable Bowel Syndrome in a Colombian Population: A Cross-Sectional Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 651, doi. 10.1007/s40801-023-00395-x
- By:
- Publication type:
- Article
Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 639, doi. 10.1007/s40801-023-00394-y
- By:
- Publication type:
- Article
Diagnosis and Treatment of Advanced ALK Rearrangement-Positive Non-Small-Cell Lung Cancer in Portugal: Results of a National Questionnaire.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 545, doi. 10.1007/s40801-023-00393-z
- By:
- Publication type:
- Article
Predictors of Pancreatitis Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab: Observation from a Large Global Safety Database.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 557, doi. 10.1007/s40801-023-00386-y
- By:
- Publication type:
- Article
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 589, doi. 10.1007/s40801-023-00391-1
- By:
- Publication type:
- Article
Signal Detection and Assessment of Herb–Drug Interactions: Saudi Food and Drug Authority Experience.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 577, doi. 10.1007/s40801-023-00388-w
- By:
- Publication type:
- Article
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 605, doi. 10.1007/s40801-023-00390-2
- By:
- Publication type:
- Article
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 565, doi. 10.1007/s40801-023-00387-x
- By:
- Publication type:
- Article
Prescribing Patterns in Pediatric General Wards and Their Association with Prescribing Errors: A Retrospective Observational Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 619, doi. 10.1007/s40801-023-00392-0
- By:
- Publication type:
- Article
Efficacy of Three Teriparatide Preparations and Romosozumab, Osteogenesis Promoters, in the Treatment of Fresh Vertebral Fractures: A Retrospective Observational Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 631, doi. 10.1007/s40801-023-00385-z
- By:
- Publication type:
- Article
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX<sup>®</sup> Pregnancy Exposure Registry.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 503, doi. 10.1007/s40801-023-00384-0
- By:
- Publication type:
- Article
Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 531, doi. 10.1007/s40801-023-00383-1
- By:
- Publication type:
- Article
Dilemma Facing Patients Aged 75 Years and Older on Fluid Restriction When Drug Package Inserts Advise Use of a Lot of Water: A Cross-Sectional, Descriptive, and Hypothesis-Generating Study Using a Large Claims Database.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 521, doi. 10.1007/s40801-023-00382-2
- By:
- Publication type:
- Article
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
- By:
- Publication type:
- Article